New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Eikon Therapeutics, Inc. (EIKN) vs Prelude Therapeutics Incorporated (PRLD)
- Eikon Therapeutics, Inc. EIKN 4.74 −0.42%
- Prelude Therapeutics Incorporated PRLD 3.23 −0.92%
Eikon Therapeutics, Inc. and Prelude Therapeutics Incorporated are both Biotechnology companies. Eikon Therapeutics, Inc. and Prelude Therapeutics Incorporated are of similar size ($260.5M and $257.9M). Across the 8 metrics below, Prelude Therapeutics Incorporated leads on 5 and Eikon Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | EIKN | PRLD | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (283.92%) | 0.00% |
| Net margin | — | (247.12%) | 0.00% |
| Free cash flow margin | — | (129.68%) | 0.00% |
| Return on equity | 359.35% | (58.36%) | (51.58%) |
| Return on assets | (56.31%) | (39.45%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack